AdaptHealth Q1 2024 GAAP EPS $(0.02) May Not Be Comparable To $0.05 Estimate, Sales $792.497M Beat $769.867M Estimate
Portfolio Pulse from Benzinga Newsdesk
AdaptHealth (NASDAQ:AHCO) reported Q1 2024 earnings with a GAAP EPS of $(0.02), missing the consensus estimate of $0.05 by 140%. However, their quarterly sales of $792.497M exceeded the estimate of $769.867M by 2.94%, marking a 6.43% increase from the previous year.
May 07, 2024 | 11:06 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
AdaptHealth reported a Q1 2024 GAAP EPS of $(0.02), missing estimates, but exceeded sales forecasts with $792.497M, a 6.43% YOY increase.
The miss on EPS estimates could negatively impact investor sentiment, but the beat on sales forecasts and year-over-year growth might offset this effect. Given the mixed results, the short-term impact on AHCO's stock price is likely to be neutral as investors weigh the underperformance in earnings against the stronger sales performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100